Navigation Links
Agency Take-up Soars of Agnitio's Leading Pull Marketing Platform for the Healthcare Industry
Date:1/17/2013

COPENHAGEN, Denmark, January 17, 2013 /PRNewswire/ --

  • 50% jump in licences over the last two months
  • Used by leading global agencies

A rapid increase in interest around Agnitio's closed loop marketing platform, has seen the global pharmaceutical marketing company experience a 50% increase in the number of licences granted to advertising, marketing and creative agencies in the last two months alone.

     (Logo: http://photos.prnewswire.com/prnh/20120924/562917-a)
     (Photo: http://photos.prnewswire.com/prnh/20120924/562917-b )

Already used by several of the leading global agencies including Publicis, CDM and Draftfcb, the Agnitio platform has the advantage of being quicker, more flexible and far less resource heavy than other options available. Agencies with rights to the platform can easily create rich content, upload it, share it with their clients and then test it.

"As well as providing the best-in-class pull marketing platform to global healthcare companies directly, we are finding that their agencies are increasingly embracing our platform," says Morten Hjelmsoe, Founder and CEO of Agnitio. "In an ever more competitive healthcare market, the Agnitio platform has the key assets of speed, ease and flexibility to allow pharma companies and their agencies to personalise and optimise interactions with their customers, maximising time and building trusted relationships."

Agnitio licences allow users to create, upload and distribute presentations. They can also facilitate the approval of any new presentation before publishing to the iPad and allow the agency to check that the presentation is generating the correct data in line with its clients' requirements. Based on HTML5, the platform is excellent for localising content and importantly negates the need and desire to produce numerous independent apps, leading to unrelated content which is both costly and difficult to control.

Headquartered in Denmark, with regional hubs in the United States, Latin America and China, Agnitio works for major firms including Bayer, Roche and Takeda, to help generate effective relationships with healthcare professionals via its platform. Through understanding doctors' individual needs and interests, highly relevant and precisely targeted information and services can be provided quickly and easily.

About Agnitio

Agnitio helps pharmaceutical and medical device companies generate effective relationships with medical professionals. The provider of the leading pull marketing software platform for the pharmaceutical and medical device industries, Agnitio's system is already implemented in more than 45 countries and 25 languages - and used by major pharmaceutical and medical device companies including: Takeda, MSD, Amgen, Roche and Bayer.


'/>"/>
SOURCE Agnitio
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
2. UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
3. DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone
4. Awareness of Omega-3 Benefits Soars
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. BioSpace Spotlights Leading Life Science Community
7. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
8. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
9. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
10. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
11. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, will ... analytical testing are being attributed to new regulatory requirements for all new drug ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
Breaking Biology Technology:
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):